Finanças

Notícias Discussões Sinais técnicos Previsão Sazonais Opções

Total de Passivos de Reviva Pharmaceuticals Holdings, Inc..

Dados anuais

2020

2021

2022

2023

‪0,00‬

‪‪5,00 M‬‬

‪‪10,00 M‬‬

‪‪15,00 M‬‬

‪‪20,00 M‬‬

Período

Valor

Variação

Variação %

2023

‪‪17,98 M‬‬

+‪‪7,45 M‬‬

+‪70,78‬%

2022

‪‪10,53 M‬‬

+‪‪7,81 M‬‬

+‪287,46‬%

2021

‪‪2,72 M‬‬

+‪‪1,38 M‬‬

+‪103,91‬%

2020

‪‪1,33 M‬‬

‪‪−904,06 K‬‬

‪−40,42‬%

Dados trimestrais

Q2 '18

Q3 '18

Q4 '18

Q1 '19

Q2 '19

Q3 '19

Q4 '19

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪0,00‬

‪‪5,00 M‬‬

‪‪10,00 M‬‬

‪‪15,00 M‬‬

‪‪20,00 M‬‬

Período

Valor

Variação

Variação %

Q3 '24

‪‪17,61 M‬‬

+‪‪3,52 M‬‬

+‪24,96‬%

Q2 '24

‪‪14,09 M‬‬

‪‪−748,25 K‬‬

‪−5,04‬%

Q1 '24

‪‪14,84 M‬‬

‪‪−3,14 M‬‬

‪−17,46‬%

Q4 '23

‪‪17,98 M‬‬

+‪‪4,08 M‬‬

+‪29,30‬%

Q3 '23

‪‪13,91 M‬‬

+‪‪3,69 M‬‬

+‪36,06‬%

Q2 '23

‪‪10,22 M‬‬

+‪‪3,10 M‬‬

+‪43,62‬%

Q1 '23

‪‪7,12 M‬‬

+‪‪509,27 K‬‬

+‪7,71‬%

Q4 '22

‪‪6,61 M‬‬

+‪‪2,93 M‬‬

+‪79,48‬%

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21

Q1 '21

Q4 '19

Q3 '19

Q2 '19

Q1 '19

Q4 '18

Q3 '18

Q2 '18